First Republic Investment Management Inc. cut its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 27.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 170,779 shares of the company’s stock after selling 66,235 shares during the period. First Republic Investment Management Inc.’s holdings in HCA Healthcare were worth $23,759,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of HCA. Signet Financial Management LLC bought a new stake in HCA Healthcare in the 2nd quarter worth about $137,000. Bridgeworth LLC bought a new stake in HCA Healthcare in the 2nd quarter worth about $173,000. Smithfield Trust Co. grew its position in HCA Healthcare by 41.2% in the 3rd quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock worth $196,000 after purchasing an additional 410 shares in the last quarter. Hyman Charles D bought a new stake in HCA Healthcare in the 2nd quarter worth about $205,000. Finally, Signition LP bought a new stake in HCA Healthcare in the 2nd quarter worth about $211,000. 69.94% of the stock is owned by institutional investors.
HCA has been the subject of a number of recent analyst reports. Barclays initiated coverage on shares of HCA Healthcare in a research report on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 price objective for the company. Morgan Stanley upped their price objective on shares of HCA Healthcare from $105.00 to $115.00 and gave the stock an “underweight” rating in a research report on Thursday, August 16th. Mizuho set a $150.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a research report on Tuesday, September 4th. Leerink Swann upped their price objective on shares of HCA Healthcare from $140.00 to $150.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 4th. Finally, SunTrust Banks upped their price objective on shares of HCA Healthcare to $150.00 and gave the stock a “positive” rating in a research report on Tuesday, September 4th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. HCA Healthcare has a consensus rating of “Buy” and an average price target of $144.15.
HCA opened at $135.86 on Friday. The stock has a market capitalization of $48.48 billion, a price-to-earnings ratio of 20.62, a P/E/G ratio of 1.24 and a beta of 0.52. HCA Healthcare Inc has a twelve month low of $84.13 and a twelve month high of $147.42.
HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.93 by $0.23. The firm had revenue of $11.45 billion for the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.13 earnings per share. As a group, equities research analysts anticipate that HCA Healthcare Inc will post 9.34 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be paid a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s payout ratio is 21.24%.
In related news, SVP Kathryn A. Torres sold 820 shares of the company’s stock in a transaction that occurred on Tuesday, November 13th. The shares were sold at an average price of $142.36, for a total transaction of $116,735.20. Following the sale, the senior vice president now directly owns 4,237 shares in the company, valued at approximately $603,179.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Deborah M. Reiner sold 723 shares of the company’s stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the sale, the senior vice president now owns 6,184 shares in the company, valued at $835,211.04. The disclosure for this sale can be found here. Insiders have sold a total of 16,763 shares of company stock worth $2,346,147 over the last 90 days. 2.80% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/12/08/first-republic-investment-management-inc-sells-66235-shares-of-hca-healthcare-inc-hca.html.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Article: How to Invest in a Bull Market
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.